May 9, 2011
De Novo Software™, a leading provider of flow and image cytometry data analysis solutions, and Molecular Devices, a provider of premiere bioresearch and drug discovery systems, announced today a licensing agreement enabling Molecular Devices to distribute De Novo Software's flagship product, FCS Express 4 Software. This supports full compatibility with the ImageXpress Velos® Cytometer (formerly IsoCyte Laser Scanning Cytometer), and a module for High Content Analysis.
Under the terms of the agreement, Molecular Devices will distribute the FCS Express 4 Image Cytometry Software to customers in the research and pharmaceutical markets worldwide. The FCS Express 4 Software can natively import ImageXpress Velos Cytometer data, for seamless visualization of multi-parametric results and corresponding images. The software also has unique integrated report generation tools pioneered by De Novo Software.
Leveraging a long history of excellence in Flow Cytometry data analysis, De Novo Software launched FCS Express 4 Image Cytometry in January of 2011. The new software adds the ability to access and interactively perform population-based analysis, while linking back to the individual images that underlie the data. This enables highlighting of individual cells in an image from selected populations or display of single cells of interest in separate cell galleries. These tools significantly improve assay development, workflow, and enable rapid report generation.
David Novo, De Novo Software's president said: "This is an ideal collaboration and business relationship, providing mature analysis and reporting tools for the ImageXpress Velos Cytometer and Molecular Devices imaging customers".
"Molecular Devices is delighted to work with De Novo Software to streamline the acquisition, analysis and reporting of high content data, enabling researchers to more easily interpret trends within complex data sets," says Jennifer McKie, Senior Marketing Director, BioImaging Products at Molecular Devices.
In FCS Express 4 analytical tools for flow and image cytometry and High Content Screening are combined into one environment with report generation and on-line collaboration tools.
Michael Sjaastad, Director of Business Development at De Novo Software commented, "This product fills a void in the cellular imaging market. There is real need for a common platform to aggregate data and images that facilitates complex analysis and reporting. We look forward to building upon this relationship to provide a general platform for data analysis and report generation used by scientists worldwide".
De Novo Software distributes software directly and through strategic partners, and will expand their distribution network in the imaging market. Customers will be able to purchase FCS Express through the Molecular Devices sales force, website and catalog.